Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer
- Garon, E.B.
- Reck, M.
- Paz-Ares, L.
- Ponce, S.
- Jaime, J.C.
- Juan, O.
- Nadal, E.
- Lee, P.
- Dalal, R.
- Liu, J.
- He, S.
- Treat, J.
- Nakagawa, K.
ISSN: 1938-0690, 1525-7304
Any de publicació: 2017
Volum: 18
Número: 1
Pàgines: 96-99
Tipus: Article